MRK - Merck & Co., Inc.
NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 217.55B |
| Enterprise value 3 | 236.76B |
| Trailing P/E | 23.88 |
| Forward P/E 1 | 15.20 |
| PEG ratio (5-yr expected) 1 | 1.75 |
| Price/sales (ttm) | 4.73 |
| Price/book (mrq) | 8.12 |
| Enterprise value/revenue 3 | 5.15 |
| Enterprise value/EBITDA 6 | 13.10 |
Trading information
Stock price history
| Beta (3Y monthly) | 0.55 |
| 52-week change 3 | 14.45% |
| S&P500 52-week change 3 | 17.89% |
| 52-week high 3 | 87.35 |
| 52-week low 3 | 70.89 |
| 50-day moving average 3 | 84.08 |
| 200-day moving average 3 | 83.23 |
Share statistics
| Avg vol (3-month) 3 | 8.16M |
| Avg vol (10-day) 3 | 8.17M |
| Shares outstanding 5 | 2.55B |
| Float | 2.54B |
| % held by insiders 1 | 0.08% |
| % held by institutions 1 | 78.28% |
| Shares short (31 Oct 2019) 4 | 19.86M |
| Short ratio (31 Oct 2019) 4 | 2.44 |
| Short % of float (31 Oct 2019) 4 | 0.77% |
| Short % of shares outstanding (31 Oct 2019) 4 | 0.78% |
| Shares short (prior month 30 Sep 2019) 4 | 21.47M |
Dividends & splits
| Forward annual dividend rate 4 | 2.44 |
| Forward annual dividend yield 4 | 2.86% |
| Trailing annual dividend rate 3 | 2.13 |
| Trailing annual dividend yield 3 | 2.49% |
| 5-year average dividend yield 4 | 3.01 |
| Payout ratio 4 | 61.45% |
| Dividend date 3 | 7 Oct 2019 |
| Ex-dividend date 4 | 13 Dec 2019 |
| Last split factor (new per old) 2 | 1/2 |
| Last split date 3 | 17 Feb 1999 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2018 |
| Most-recent quarter (mrq) | 30 Sep 2019 |
Profitability
| Profit margin | 20.26% |
| Operating margin (ttm) | 31.60% |
Management effectiveness
| Return on assets (ttm) | 10.78% |
| Return on equity (ttm) | 30.86% |
Income statement
| Revenue (ttm) | 45.97B |
| Revenue per share (ttm) | 17.80 |
| Quarterly revenue growth (yoy) | 14.90% |
| Gross profit (ttm) | 28.81B |
| EBITDA | 18.08B |
| Net income avi to common (ttm) | 9.31B |
| Diluted EPS (ttm) | 3.58 |
| Quarterly earnings growth (yoy) | -2.50% |
Balance sheet
| Total cash (mrq) | 8.02B |
| Total cash per share (mrq) | 3.15 |
| Total debt (mrq) | 27.11B |
| Total debt/equity (mrq) | 100.69 |
| Current ratio (mrq) | 1.26 |
| Book value per share (mrq) | 10.52 |
Cash flow statement
| Operating cash flow (ttm) | 12.24B |
| Levered free cash flow (ttm) | 9.74B |